Last reviewed · How we verify
TESI
At a glance
| Generic name | TESI |
|---|---|
| Also known as | Transforaminal epidural steroid injections |
| Sponsor | Montefiore Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Thrombocytopenia
- Increased gamma-glutamyltransferase
- Neutropenia
- Anemia
- Hyperglycemia
- Transaminase elevation
- Fatigue
- Hypoalbuminemia
- Rash
- Edema
- Nausea
- Musculoskeletal pain
Serious adverse events
- Febrile neutropenia
- Pneumonia
- Edema
- Pleural effusion
- Sepsis
- Infection (fatal)
- Serious adverse reactions (overall)
Key clinical trials
- A Model for Continuous Care of Fragile Patients
- Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy (PHASE1)
- Epidural Steroid Injections in Post-lumbar Surgery Syndrome After Single-level Discectomy (NA)
- Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy (PHASE4)
- The Effect of Transcranial Magnetic Stimulation Therapy in Patients With Lumbar Radiculopathy (NA)
- Epidural Contrast Flow Patterns of TESI Using the Inferior-Anterior Position as the Final Needle Tip Position.
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TESI CI brief — competitive landscape report
- TESI updates RSS · CI watch RSS
- Montefiore Medical Center portfolio CI